Core Binding Factor Acute Myeloid Leukemia in Pediatric Patients Enrolled in the AIEOP AML 2002/01 Trial: The Impact of Minimal Residual Disease on Patient Outcome

被引:0
|
作者
Pigazzi, Martina [1 ]
Beqiri, Valzerda [1 ]
Manara, Elena [1 ]
Bisio, Valeria [1 ]
Rondelli, Roberto [2 ]
Masetti, Riccardo [2 ]
Rizzari, Carmelo [3 ]
Putti, Maria Caterina [1 ]
Pession, Andrea [2 ]
Locatelli, Franco [4 ]
Basso, Giuseppe [1 ]
机构
[1] Univ Padua, Dipartimento Salute Donna & Bambino, Padua, Italy
[2] Univ Bologna, Clin Pediat, Osped S Orsola, Bologna, Italy
[3] Univ Milano Bicocca, Clin Pediat, Fdn MBBM, Osped S Gerardo, Monza, Italy
[4] IRCCS Osped Pediat Bambino Gesu, Rome, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:322 / 322
页数:1
相关论文
共 50 条
  • [1] THE IMPACT OF MOLECULAR MINIMAL RESIDUAL DISEASE MONITORING IN PEDIATRIC PATIENTS WITH CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA ENROLLED IN THE AIEOP AML 2002/01 PROTOCOL
    Pigazzi, M.
    Manara, E.
    Buldini, B.
    Beqiri, V.
    Bisio, V.
    Tregnago, C.
    Rondelli, R.
    Masetti, R.
    Putti, M. C.
    Fagioli, F.
    Rizzari, C.
    Pession, A.
    Franco, L.
    Basso, G.
    [J]. HAEMATOLOGICA, 2014, 99 : 309 - 309
  • [2] Core Binding Factor Acute Myeloid Leukemia in Pediatric Patients of the AIEOP AML 2002/01 Trial: Screening and Prognostic Impact of CKIT Mutations
    Manara, Elena
    Bisio, Valeria
    Beqiri, Valzerda
    Rondelli, Roberto
    Menna, Giuseppe
    Micalizzi, Concetta
    Santoro, Nicola
    Locatelli, Franco
    Basso, Giuseppe
    Pigazzi, Martina
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2014, 36 (04) : 323 - 323
  • [3] Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: screening and prognostic impact of c-KIT mutations
    Manara, E.
    Bisio, V.
    Masetti, R.
    Beqiri, V.
    Rondelli, R.
    Menna, G.
    Micalizzi, C.
    Santoro, N.
    Locatelli, F.
    Basso, G.
    Pigazzi, M.
    [J]. LEUKEMIA, 2014, 28 (05) : 1132 - 1134
  • [4] Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: screening and prognostic impact of c-KIT mutations
    E Manara
    V Bisio
    R Masetti
    V Beqiri
    R Rondelli
    G Menna
    C Micalizzi
    N Santoro
    F Locatelli
    G Basso
    M Pigazzi
    [J]. Leukemia, 2014, 28 : 1132 - 1134
  • [5] Favourable Outcome in Infants with Acute Myeloid Leukemia Treated with the AIEOP AML 2002/01 Protocol
    Masetti, Riccardo
    Pigazzi, Martina
    Pession, Andrea
    Rizzari, Carmelo
    Santoro, Nicola
    Nigro, Luca Io
    Luciani, Matteo
    Menna, Giuseppe
    Rondelli, Roberto
    Basso, Giuseppe
    Locatelli, Franco
    [J]. BLOOD, 2012, 120 (21)
  • [6] Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia
    Pession, Andrea
    Masetti, Riccardo
    Rizzari, Carmelo
    Putti, Maria Caterina
    Casale, Fiorina
    Fagioli, Franca
    Luciani, Matteo
    Lo Nigro, Luca
    Menna, Giuseppe
    Micalizzi, Concetta
    Santoro, Nicola
    Testi, Anna Maria
    Zecca, Marco
    Biondi, Andrea
    Pigazzi, Martina
    Rutella, Sergio
    Rondelli, Roberto
    Basso, Giuseppe
    Locatelli, Franco
    [J]. BLOOD, 2013, 122 (02) : 170 - 178
  • [7] Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial
    Quarello, Paola
    Fagioli, Franca
    Basso, Giuseppe
    Putti, Maria C.
    Berger, Massimo
    Luciani, Matteo
    Rizzari, Carmelo
    Menna, Giuseppe
    Masetti, Riccardo
    Locatelli, Franco
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (04) : 566 - 573
  • [8] Minimal Residual Disease Eradication by Azacitidine Maintenance in a Patient with Core-Binding Factor Acute Myeloid Leukemia
    Yucel, Orhan Kemal
    Alemdar, Mustafa Serkan
    Atas, Unal
    Undar, Levent
    [J]. CHEMOTHERAPY, 2021, 65 (5-6) : 166 - 170
  • [9] Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia
    Jourdan, Eric
    Boissel, Nicolas
    Chevret, Sylvie
    Delabesse, Eric
    Renneville, Aline
    Cornillet, Pascale
    Blanchet, Odile
    Cayuela, Jean-Michel
    Recher, Christian
    Raffoux, Emmanuel
    Delaunay, Jacques
    Pigneux, Arnaud
    Bulabois, Claude-Eric
    Berthon, Celine
    Pautas, Cecile
    Vey, Norbert
    Lioure, Bruno
    Thomas, Xavier
    Luquet, Isabelle
    Terre, Christine
    Guardiola, Philippe
    Bene, Marie C.
    Preudhomme, Claude
    Ifrah, Norbert
    Dombret, Herve
    [J]. BLOOD, 2013, 121 (12) : 2213 - 2223
  • [10] Minimal residual disease eradication with epigenetic therapy in core binding factor acute myeloid leukemia
    Ragon, Brittany Knick
    Daver, Naval
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Cortes, Jorge
    Kadia, Tapan
    Oran, Betul
    Ohanian, Maro
    Ferrajoli, Alessandra
    Pemmaraju, Naveen
    Kantarjian, Hagop M.
    Borthakur, Gautam
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (09) : 845 - 850